Shire agrees to test its ADHD drug in preschool children

June 12, 2014 1:55 PM

4 0

LONDON (Reuters) - London-listed drugmaker Shire PLC said it had agreed to a request from the U.S. regulator to test the use of its amphetamine-based drug Vyvanse in preschool children aged four and five with hyperactivity.

The FDA, the U.S. regulator, says the drug should be prescribed for patients aged six years or above.

Also read: Alcobra's ADHD drug fails late-stage study

Read more

To category page